의료용 생성형 AI 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global generative AI in healthcare market size is expected to reach USD 43.69 Billion in 2034 from USD 3.25 Billion in 2025, growing at a CAGR of 33.47 during 2026-2034.The global generative AI in healthcare market is witnessing rapid growth as healthcare providers increasingly adopt advanced digital solutions. Generative AI is being used for medical imaging analysis, drug discovery, patient data management, and clinical documentation automation. The rising need to improve operational efficiency and reduce healthcare costs is driving strong interest in AI-powered technologies.

Growing investments in health tech startups and strategic collaborations between technology companies and healthcare organizations are accelerating innovation. Generative AI models help in predictive analytics, personalized treatment planning, and faster research outcomes. The increasing availability of healthcare data and advancements in cloud computing are further fueling market growth.

Looking ahead, the market is expected to expand significantly as regulatory frameworks become clearer and AI adoption becomes more widespread. Integration of generative AI with telemedicine and electronic health records will enhance patient care delivery. With continuous technological advancements, generative AI is poised to transform healthcare systems globally.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Component

• Solutions
• Service

By Function

• Virtual Nursing Assistants
• Robot-Assisted AI Surgery
• Administrative Process Optimization
• Medical Imaging Analysis

By End Use

• Clinical Research
• Medical Centers
• Diagnostic Centers
• Others

By Application

• Clinical
• System

COMPANIES PROFILED

• Google LLC, IBM Watson, Johnson & Johnson, Microsoft Corporation, Neuralink Corporation, OpenAI, Oracle Corporation, Syntegra, Tencent Holdings Ltd

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Service Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET: BY FUNCTION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Function
• 5.2. Virtual Nursing Assistants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Robot-Assisted AI Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Administrative Process Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Medical Imaging Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Medical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. System Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Function
  • 8.2.3 By End Use
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Function
  • 8.3.3 By End Use
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Function
  • 8.4.3 By End Use
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Function
  • 8.5.3 By End Use
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Function
  • 8.6.3 By End Use
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENERATIVE AI IN HEALTHCARE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Google LLC
  • 10.2.2 IBM Watson
  • 10.2.3 Johnson & Johnson
  • 10.2.4 Microsoft Corporation
  • 10.2.5 Neuralink Corporation
  • 10.2.6 OpenAI
  • 10.2.7 Oracle Corporation
  • 10.2.8 Syntegra
  • 10.2.9 Tencent Holdings Ltd